INTRODUCTION
============

Voltage-gated sodium (Na~v~) channels constitute a welcome target for venomous animals seeking to disrupt the transmission of electrical signals to incapacitate prey or defend against predators ([@bib15]). To this end, peptide toxins within these venoms have evolved to interact with a specific region within each of the four Na~v~ channel voltage-sensing domains (VSDs), the S3b--S4 helix-turn-helix motif or paddle motif ([@bib13]). The pharmacological importance of this distinct region was first recognized in voltage-gated potassium (K~v~) channels where mutations in the S3b--S4 loop reduced channel sensitivity to hanatoxin, a founding member of the K~v~ channel gating modifier toxin family ([@bib19]). Later, structural information revealed that the paddle motif makes few contacts with the rest of the channel protein ([@bib20]; [@bib31]), which prompted experiments in which the S3b--S4 region was swapped between voltage-gated ion channels without disrupting the voltage-sensing process ([@bib1]). The paddle motif was also identified in each of the four Na~v~ channel voltage sensors, and transferring these regions from mammalian or insect Na~v~ to K~v~ channels resulted in functional K~v~ channels that are sensitive to an array of Na~v~ channel toxins ([@bib6], [@bib7]; [@bib2]). One recurring outcome of these studies is that K~v~ channels containing the VSD IV paddle motif of donor Na~v~ channels possess slower kinetics when compared with constructs containing paddle motifs from the other three VSDs. These observations fit well with the notion that VSD I--III activation in response to changes in membrane voltage is most important for channel opening, whereas VSD IV plays a distinct role in fast inactivating the channel after it has opened ([@bib5]; [@bib8]). As such, animal toxins that interact with the paddle motif in VSD I--III generally disrupt channel opening, whereas those that primarily target VSD IV commonly inhibit fast inactivation ([@bib6]).

Here, our goal was to examine whether the paddle motif is pharmacologically functional when isolated from its channel background. A positive outcome would be particularly exciting for designing assays geared toward discovering novel ligands that target this region. For example, recent developments with antibodies targeting Na~v~ channel paddles suggest that they may serve as drug targets or diagnostic markers ([@bib11]; [@bib17]). Given its unique role in channel fast inactivation as well as its discerning sensitivity to animal toxins, we chose to focus on the VSD IV paddle motif and provide proof-of-principle experiments for this concept by synthesizing the paddle peptide and fixing it on sensor chips to be used in surface plasmon resonance (SPR) measurements. In brief, this label-free optical approach uses polarized light to measure the refractive index near a sensor surface to which a molecule of interest ("ligand" in SPR terminology) is attached. When a soluble particle ("analyte" in SPR terminology) binds, surface protein accumulation results in a refractive index alteration that can be measured in real time. The results are then plotted as response or resonance units (RUs) versus time in a "sensorgram." By fitting kinetics from the association and dissociation phase to a particular adsorption model, the corresponding kinetic rate constants can be calculated ([@bib24]; [@bib29]). As partnering analytes, we decided upon α-scorpion toxins, which are small cysteine-rich proteins that potently bind to the VSD IV paddle motif to inhibit Na~v~ channel fast inactivation ([@bib27]; [@bib13]). Ensuing SPR experiments would determine kinetic or affinity constants between the VSD IV paddle motif and α-scorpion toxins without the need for fluorescent or radioactive probe labeling.

MATERIALS AND METHODS
=====================

Two-electrode voltage-clamp recordings from *Xenopus laevis* oocytes
--------------------------------------------------------------------

The DNA sequence of rat (r)Na~v~1.2a (provided by A. Goldin, University of California, Irvine, Irvine, CA), rK~v~2.1 (provided by K.J. Swartz, National Institutes of Health), and the rNa~v~1.2a/K~v~2.1 VSD II or IV chimera was confirmed by automated DNA sequencing, and cRNA was synthesized using T7 polymerase (mMessage mMachine kit; Life Technologies) after linearizing the DNA with appropriate restriction enzymes. Channels were expressed in *Xenopus* oocytes (obtained from Xenopus 1) and studied after a 1-d incubation after cRNA injection (incubated at 17°C in 96 mM NaCl, 2 mM KCl, 5 mM HEPES, 1 mM MgCl~2~, 1.8 mM CaCl~2~, and 50 µg/ml gentamycin, pH 7.6 with NaOH) using two-electrode voltage-clamp recording techniques (OC-725C; Warner Instruments) with a 150-µl recording chamber. Data were filtered at 4 kHz and digitized at 20 kHz using pClamp 10 software (Molecular Devices). Microelectrode resistances were 0.5--1.5 MΩ when filled with 3 M KCl. For K~v~ chimera channel experiments, the external recording solution contained (mM): 50 KCl, 50 NaCl, 5 HEPES, 1 MgCl~2~, and 0.3 CaCl~2~, pH 7.6 with NaOH. For rNa~v~1.2a experiments, the external recording solution contained (mM): 100 NaCl, 5 HEPES, 1 MgCl~2~, and 1.8 CaCl~2~, pH 7.6 with NaOH. All experiments were performed at ∼22°C. Leak and background conductances, identified by blocking the channel with agitoxin-2 (provided by K.J. Swartz), have been subtracted for all of the K~v~ channel currents shown. Tetrodotoxin (Alomone Labs) subtraction was used to isolate Na~v~ channel currents. After the addition of the toxin to the recording chamber, the equilibration between the toxin and the channel was monitored using weak depolarizations elicited at 5- or 10-s (R1629A/L1630A mutant) intervals. Voltage--activation relationships were obtained by measuring tail currents for K~v~ channels or steady-state currents and calculating conductance for Na~v~ channels, and a single Boltzmann function was fitted to the data according to I/I~max~ = \[1c + cexp(−*zF*(Vc − cV~1/2~)/*RT*)\]^−1^, where I/I~max~ is the normalized tail-current amplitude, *z* is the equivalent charge, V~1/2~ is the half-activation voltage, *F* is Faraday's constant, *R* is the gas constant, and *T* is temperature in kelvin. For all channels, we recorded voltage--activation relationships in the absence and presence of toxin. The ratio of currents (I/I~0~) recorded in the presence (I) and absence (I~0~) of toxin was calculated for voltages typically ranging from −140 to 10 cmV, depending on the construct. The value of I/I~0~ measured in the plateau phase at voltages where toxin-bound channels do not open was taken as Fu. The apparent equilibrium dissociation constant (apparent K~D~) for K~v~ channels was calculated according to K~D~ = ((1/(1c − cFu^1/4^))c − c1)\[toxin\], assuming four independent toxin-binding sites per channel ([@bib32]). Results are given as mean ± SEM unless noted otherwise. Offline data analysis was performed using Clampfit 10 (Molecular Devices), Origin 8.0 (OriginLab), and Excel (Microsoft). All chemicals were obtained from Sigma-Aldrich.

Peptide synthesis
-----------------

VSD II and IV paddle peptides of rNa~v~1.2a were produced using standard Fmoc solid-phase peptide synthesis on preloaded Fmoc--amino acid Wang resin, HPLC purified (\>99.5% purity), and tested for the correct mass using mass spectrometry by ProteoGenix. Circular dichroism (CD) measurements were performed in a standard PBS solution containing 0.1% vol/vol lauryldimethylamine *N*-oxide on a spectropolarimeter (J-810; JASCO).

SPR experiments
---------------

SPR experiments were performed at 25°C on a Biacore T200 instrument (GE Healthcare) using 150 mM NaCl, 3 mM EDTA, 0.005% surfactant P20, and 10 mM HEPES-NaOH, pH 7.4, for the coupling protocol or 50 mM phosphate, pH 7.2, as running buffer. Neutravidin (Thermo Fisher Scientific) was immobilized on CM5 sensor chips (GE Healthcare) using an amine coupling chemistry. All chemicals were obtained from Sigma-Aldrich. Biotinylated paddle peptides (ligands) were injected in experimental flow cells, as well as a SNAP-25-Biotin peptide of comparable length (t-SNARE protein from residues 137 to 206; [@bib30]) in control flow cells to obtain 50 or 500 fmol of immobilized peptide for kinetic or binding analysis, respectively. In all SPR experiments, nonspecific binding obtained in the control flow cell was subtracted from the signal obtained in the experimental flow cell. For qualitative binding analysis, toxins (100 nM in running buffer containing 0.1% BSA) were injected at a flow rate of 20 µl/min over 2 min. For kinetic studies, varying toxin concentrations (15--2,000 nM) were injected at a flow rate of 20 µl/min. In between injections, the surface of the sensor chip was regenerated by injecting 1 M NaCl (15 s at 30 µl/min). The bulk signal caused by refractive index differences between the flow buffer and the buffer containing the analyte was systematically excluded from the data-fitting process. It is worth noting that isolating a paddle motif (ligand) can induce conformational changes that can affect toxin (analyte) efficacy. In fact, the CD spectrum in [Fig. 3 A](#fig3){ref-type="fig"} suggests the presence of an unstructured VSD IV peptide region or pool (∼25%), which may alter toxin susceptibility. Sensorgrams can reveal such ligand heterogeneity by displaying biphasic dissociation curves that cannot be fitted with the frequently used Langmuir model, which assumes a 1:1 stoichiometry of analyte to ligand. To account for a possible heterogeneity of surface sites, we calculated the rate constants and affinity equilibrium dissociation constants (K~D~) for AaHII by a fit to a heterogeneous ligand model ([@bib29]) incorporated into the Biacore T200 Evaluation software (v1.0). This model assumes the presence of two sites on the ligand that can bind analyte and can be described by these equations in which A represents the analyte and B1/B2 represents the heterogeneous ligand:$$A + B1\underset{k_{d1}}{\overset{k_{a1}}{\rightleftarrows}}{AB}1;\, A + B2\underset{k_{d2}}{\overset{k_{a2}}{\rightleftarrows}}{AB}2.$$

Calculating the K~D~ values involves these components: dB1/dt = −(k~a1~\*A\*B1 − k~d1~\*AB1); dB2/dt = −(k~a2~\*A\*B2 − k~d2~\*AB2); dAB1/dt = (k~a1~\*A\*B1 − k~d1~\*AB1); dAB2/dt = (k~a2~\*A\*B2 − k~d2~\*AB2), with A = analyte concentration, B1 = RU~max1~ of a particular binding site, B2 = RU~max2~, k~a~ and k~d~ = association and dissociation rate constant, and AB1 and AB2 = 0 at the start of each experiment (no complex has been formed). Note that two separate sets of k~a~ and k~d~ constants as well as two K~D~ values describe each binding event.

RESULTS
=======

The four Na~v~ channel--selective α-scorpion toxins we selected for our experiments were AaHI and AaHII from *Androctonus australis* Hector, LqqV from *Leiurus quinquestriatus hebraeus*, and BomIV from *Buthus occitanus mardochei* ([@bib22]; [@bib2]). As negative control, we applied kaliotoxin (KTX) from *Androctonus mauretanicus*, which blocks the K~v~1.1 and K~v~1.3 pore but does not influence Na~v~ channel function ([@bib12]). All toxins were purified to homogeneity as reported previously ([@bib12]; [@bib22]) and tested for functionality on the rNa~v~1.2a isoform expressed in *Xenopus* oocytes. In all cases, the application of 100 nM AaHI, AaHII, LqqV, or BomIV inhibits rNa~v~1.2a fast inactivation, resulting in the appearance of a large persistent current at the end of a 50-ms test pulse ([Fig. 1 A](#fig1){ref-type="fig"}). Because AaHII has already been shown to bind to the VSD IV paddle motif in rNa~v~1.2a ([@bib6]), we verified if this was also the case with AaHI, LqqV, and BomIV. To this end, we tested whether 100 nM of each toxin influenced the function of a previously constructed chimera in which the S3b--S4 region of the homotetrameric K~v~2.1 channel was swapped for the corresponding WT region in VSD IV from rNa~v~1.2a. As a result, we observed a robust voltage-dependent K^+^ current inhibition, whereas WT K~v~2.1 is insensitive, suggesting that AaHI, LqqV, and BomIV indeed interact with the transferred VSD IV paddle motif ([Fig. 1, B and C](#fig1){ref-type="fig"}).

![α-Scorpion toxins interact with the rNa~v~1.2a VSD IV paddle motif. (A) Shown is the effect of 100 nM AaHI, AaHII, LqqV, and BomIV on rNa~v~1.2a channel function. Representative sodium currents were elicited by a 50-ms depolarization to a suitable membrane voltage (−20 to −15 mV) before (black) and after toxin addition (green) from a holding voltage of −90 mV. Clearly, toxin application results in a large persistent current component at the end of the test pulse. Fitting the current decay with a single-exponential function before and after toxin application yields fast inactivation time constants (τ) of 3.2 ± 0.1 and 4.7 ± 0.1 (AaHI); 3.6 ± 0.2 and 4.9 ± 0.1 (AaHII); 2.5 ± 0.1 and 4.6 ± 0.1 (LqqV); and 2.9 ± 0.1 and 8.5 ± 0.1 (BomIV), with *n* = 3 for each value (mean ± SEM). (B) Shown is the effect of 1 µM AaHI, LqqV, and BomIV on WT rK~v~2.1. For each toxin, K^+^ currents were elicited by a 300-ms depolarization to 0 mV from a holding voltage of −90 mV (tail voltage was −60 mV). Currents are shown before (black) and in the presence of toxin (green). (C) Effect of 100 nM AaHI, LqqV, and BomIV on the rNa~v~1.2a/K~v~2.1 VSD IV paddle chimera. For each toxin, K^+^ currents (top) were elicited by a 300-ms depolarization near the foot of the voltage--activation curve (bottom) from a holding voltage of −90 mV. Currents are shown before (black) and in the presence of toxin (green). Representative normalized tail current voltage--activation relationships are shown (bottom), where tail current amplitude (I/I~max~) is plotted against test voltage (V) before (black) and in the presence of toxins (green). A Boltzmann fit of the obtained data (*n* = 3; mean ± SEM) reveals a depolarizing shift in midpoint (V~1/2~) of ∼15 mV for AaHI, \>50 mV for LqqV, and ∼26 mV for BomIV. Holding voltage was −90 mV, and the tail voltage was −60 mV.](JGP_201411268_Fig1){#fig1}

To design the best possible environment for detecting toxin--paddle interactions in our SPR experiments, the isolated VSD IV paddle peptide of rNa~v~1.2a as defined previously ([@bib6]) was synthesized with two amino acid substitutions (R1629A/L1630A) that each were shown to increase susceptibility to our model toxin AaHII ([Fig. 2 A](#fig2){ref-type="fig"}). Specifically, the affinity of AaHII for the WT rNa~v~1.2a/K~v~2.1 VSD IV chimera (apparent K~D~ = 1,902 ± 102 nM) increased to 235 ± 24 nM (R1629A) and 205 ± 23 nM (L1630A). To verify the affinity of AaHII for the double mutant, we introduced R1629A/L1630A into the rNa~v~1.2a/K~v~2.1 VSD IV chimera and expressed the construct in *Xenopus* oocytes. Compared with the tail current voltage--activation relationship of the WT chimera, the R1629A/L1630A substitutions cause a striking hyperpolarizing shift in midpoint (ΔV~1/2~ of approximately −112 mV; [Fig. 2 B](#fig2){ref-type="fig"}). However, it is also clear that 100 nM AaHII strongly inhibits the double mutant, whereas the WT rNa~v~1.2a/K~v~2.1 VSD IV chimera is influenced to a much lesser extent ([Fig. 2 B](#fig2){ref-type="fig"}).

![AaHII interacts with the rNa~v~1.2a VSD IV paddle motif. (A) Na~v~ channel cartoon embedded in a lipid membrane. Each domain (DI--IV) consists of six transmembrane segments (S1--S6) of which S1--S4 form the VSD and the S5--S6 segments of each domain form the pore. Paddle motif amino acid sequences are shown for VSD II (red) and IV (green). Underlined residues were mutated as reported in Results. (B) Effect of 100 nM AaHII on the rNa~v~1.2a/K~v~2.1 VSD IV chimera containing the R1629A/L1630A substitutions. K^+^ current (left) was elicited by a 300-ms depolarization to −100 mV (tail voltage was −150 mV) after a 500-ms step to −150 mV from a holding voltage of −10 mV (near the Nernst potential for K^+^). The data show a clear toxin-induced inhibition of the double mutant channel (black, control; green, 100 nM AaHII). Right panel displays normalized tail current voltage--activation relationships of the rNa~v~1.2a/K~v~2.1 VSD IV chimera without (open circles) and with the R1629A/L1630A substitutions (closed circles) where tail current amplitude (I/I~max~) is plotted against test voltage before (black) and in the presence of 100 nM AaHII (green). Holding voltage for the mutant was −10 mV, followed by a 500-ms hyperpolarizing step to −150 mV to close all channels. Next, 10-mV step depolarizations of 300 ms (V) were trailed by a 300-ms tail voltage step to −150 mV (I). A Boltzmann fit of the obtained data (*n* = 3; error bars represent mean ± SEM) reveals a shift in midpoint (V~1/2~) for the double mutant (−105 ± 1 mV; slope, 17.1 ± 1.0) compared with the rNa~v~1.2a/K~v~2.1 VSD IV chimera (7 ± 2 mV; slope, 17.3 ± 1.6). Moreover, 100 nM AaHII strongly inhibits the double mutant (apparent K~D~ = 193 ± 42 nM), whereas the rNa~v~1.2a/K~v~2.1 VSD IV chimera is influenced less (apparent K~D~ = 1,008 ± 92 nM), with *n* = 3 for each value (error bars represent mean ± SEM).](JGP_201411268_Fig2){#fig2}

Next, we fixed the VSD IV peptide on SPR sensor chips by adding a K-linked biotin group to the C terminus, resulting in a 32--amino acid peptide altogether ([Fig. 2 A](#fig2){ref-type="fig"}). This biotin moiety may improve toxin access to its binding site and avoid steric hindrance when the paddle peptide is linked to the sensor chips. Also, the biotin group was attached to the C terminus, as amino acids crucial for AaHII binding are mostly located at the N-terminal region of the rNa~v~1.2a VSD IV paddle ([@bib6]). CD measurements reveal that the peptide folds and mainly adopts an α-helical conformation (∼53%; [Fig. 3 A](#fig3){ref-type="fig"}), an observation that fits well with an earlier report about the NMR solution structure of an isolated paddle motif from the HsapBK K~v~ channel ([@bib34], [@bib35]). To serve as a control for toxins interacting exclusively with the VSD IV paddle motif, we also synthesized the previously defined VSD II paddle motif of rNa~v~1.2a, including a V843A gain-of-function mutation and a C-terminal K-linked biotin group ([@bib6]; [@bib38]). Altogether, this peptide comprises 26 amino acids ([Fig. 2 A](#fig2){ref-type="fig"}), and similar to VSD IV, CD measurements of the VSD II paddle motif reveal a folded peptide that mainly adopts an α-helical conformation ([Fig. 3 A](#fig3){ref-type="fig"}). For SPR experiments, biotinylated paddle peptides were injected in experimental flow cells to obtain ∼50 or 500 fmol of immobilized peptides for kinetic or binding analysis, respectively.

We started by examining the interaction of AaHII with the VSD IV paddle motif using toxin concentrations ranging from 15 to 2,000 nM. As shown in [Fig. 3 B](#fig3){ref-type="fig"}, concentration-dependent association and biphasic dissociation curves ranging from 0 to 100 RUs were obtained, thereby suggesting a possible heterogeneity of biosensor surface sites that may be related to toxin interaction with an unstructured paddle motif region (see [Fig. 3 A](#fig3){ref-type="fig"}, Materials and methods, and [@bib29]). Fits of these sensorgrams using a heterogeneous ligand model yielded two sets of association (k~a~) and dissociation (k~d~) rates, i.e., k~a1~ = 2.33 × 10^3^ ± 0.91 × 10^3^ M^−1^ s^−1^ and k~a2~ = 3.82 × 10^4^ ± 0.47 × 10^4^ M^−1^ s^−1^, and k~d1~ = 9.79 × 10^−4^ ± 1.40 × 10^−4^ s^−1^ and k~d2~ = 2.81 × 10^−2^ ± 0.58 × 10^−2^ s^−1^, resulting in a high affinity K~D1~ (k~d1~/k~a1~) of 479 ± 241 nM (RU~max1~ = 135) and a lower affinity K~D2~ (k~d2~/k~a2~) of 747 ± 203 nM (RU~max2~ = 23), which may represent a partially active binding site (*n* = 3; all results presented as mean ± SD). Although comparing diverse affinity measurements obtained from different systems is not straightforward, K~D1~ resembles that observed when determining the susceptibility of the rNa~v~1.2a/K~v~2.1 VSD IV R1629A/L1630A paddle chimera for AaHII (apparent K~D~ is 193 ± 42 nM; [Fig. 2 B](#fig2){ref-type="fig"}). The affinity of the toxin for WT rNa~v~1.2a is ∼5 nM, suggesting that regions outside of the VSD IV paddle motif may enhance toxin efficacy ([@bib37]). However, such secondary interactions seem more crucial for toxins interacting with VSD II ([@bib9], [@bib10]; [@bib18]; [@bib16]; [@bib39]; [@bib2]), a notion that we will explore in the next section. Overall, the biological activity of AaHII in our SPR assay suggests an intrinsic pharmacological sensitivity of the isolated rNa~v~1.2a VSD IV paddle motif and demonstrates the effectiveness of the SPR technique in determining ligand interactions with this region. In contrast to the VSD IV peptide, we did not notice an effect of AaHII when applying up to 20 µM toxin to sensor chips coated with the VSD II paddle motif ([Fig. 3, C and D](#fig3){ref-type="fig"}). In concordance, no interaction was observed when assaying AaHII on the rNa~v~1.2a/K~v~2.1 VSD II paddle chimera ([@bib6]). To further evaluate the robustness of the SPR approach reported here, we examined whether the α-scorpion toxins AaHI, LqqV, and BomIV also interact with the isolated VSD IV paddle peptide at a concentration of 100 nM. We indeed found that all four toxins bind this motif with RUs of ∼40--60, whereas we were unable to obtain a response when testing the VSD II peptide ([Fig. 3, C and D](#fig3){ref-type="fig"}).

![α-Scorpion toxins interact with the isolated rNa~v~1.2a VSD IV paddle motif. (A) Shown are the CD spectra of the rNa~v~1.2a VSD II and IV paddle peptides used in this paper. Analysis of both spectra revealed the presence of ∼75% structured (α-helix/β-sheet) and ∼25% unstructured peptide. Inset shows the crystal structure of the NavAb voltage sensor (3RVY) ([@bib25]) in which the paddle motif is indicated in green; wheat shows S1 and S2 helices, and white indicates the portion of S3 and S4 helices outside the paddle. (B) Representative association and dissociation kinetic curves obtained using SPR after the application of varying concentrations of AaHII (15--2,000 nM) over a sensor chip to which 50 fmol of the rNa~v~1.2a VSD IV paddle peptide was linked. Toxin was applied after obtaining a steady baseline. Colored traces represent toxin binding obtained after subtraction of the signal from the control flow cell. Green dotted lines depict a fit of the data to a heterogeneous surface ligand model, a typical SPR analysis method ([@bib29]), which yielded a high affinity K~D1~ of 479 ± 241 nM (RU~max1~ = 135) and a lower affinity K~D2~ of 747 ± 203 nM (RU~max2~ = 23; *n* = 3; all results presented as mean ± SD). The respective contributions of RU~max1~ (∼85%) and RU~max2~ (∼15%) to the overall RU~max~ (100%) are reminiscent of the percent structured (∼75%) versus unstructured (∼25%) paddle peptide as observed in the CD spectrum. Toxin concentrations are indicated on the right in a shade of gray corresponding to the sensorgram. (C) Representative SPR traces after the application of 100 nM KTX, AaHI, AaHII, LqqV, BomIV, TsVII, and CssIV over a sensor chip to which the rNa~v~1.2a VSD II (left) or IV (right) paddle peptide (500 fmol) was linked. Toxin was applied after obtaining a steady baseline. (D) Binding capacities of 100 nM α-scorpion toxins AaHI, AaHII, LqqV, the α-like scorpion toxin BomIV, and the β-scorpion toxins TsVII and CssIV to the VSD II and IV paddle motifs using SPR (error bars represent ± SEM). Y-axis represents the maximum RUs obtained after toxin application. Note that 500 fmol paddle peptide was used in C and D as opposed to 50 fmol in B. As a result, RUs differ by a factor of ∼10.](JGP_201411268_Fig3){#fig3}

To verify the proper function of the VSD II paddle motif peptide in this SPR assay, we first applied 100 nM TsVII, a β-scorpion toxin from the Brazilian scorpion *Tityus serrulatus*, which promotes opening of rNa~v~1.2a (apparent K~D~ ranges from 25 to 121 nM) by primarily interacting with the paddle motif in the domain II voltage sensor with an apparent K~D~ of 112 ± 12 nM ([@bib6]). However, electrophysiological data from the rNa~v~1.2a/K~v~2.1 chimeras revealed that TsVII can also bind to the VSD IV paddle ([@bib6]). In concert, both paddle motifs responded to the presence of TsVII in SPR experiments ([Fig. 3, C and D](#fig3){ref-type="fig"}), thereby indicating that sensor chips containing the VSD II or IV paddle motifs are capable of binding appropriate ligands. Also, the K~v~ channel toxin KTX serving as a negative control did not bind to either of the two paddle motif peptides ([Fig. 3, C and D](#fig3){ref-type="fig"}). In contrast to α-scorpion toxins for which an interaction with the VSD IV paddle motif seems sufficient to exert their effect ([@bib27]; [@bib4]; [@bib6]; [@bib14]; [@bib37]), it is important to mention that residues outside of the VSD II paddle motif are required for proper binding of β-scorpion toxins such as CssIV from *Centruroides suffusus* *suffusus* ([@bib9], [@bib10]; [@bib18]; [@bib16]; [@bib39]). Because these interactions are lost when isolating the VSD II paddle motif on an SPR chip, it is reasonable to assume that our assay may not detect binding of particular β-scorpion toxins. To investigate this possibility, we tested whether CssIV ([@bib21]) elicited an SPR response when applied to the VSD II or IV paddle motif. Indeed, no RUs could be detected upon the addition of 100 nM CssIV ([Fig. 3, C and D](#fig3){ref-type="fig"}), a concentration that clearly influences WT rNa~v~1.2a gating ([@bib9], [@bib10]). Correspondingly, 1 µM CssIV is required to begin inhibiting the rNa~v~1.2a/K~v~2.1 VSD II paddle chimera ([Fig. 4](#fig4){ref-type="fig"}), thereby supporting the notion that regions outside of the paddle motif may indeed be crucial for β-scorpion toxin binding. Subsequently, the SPR approach described here is limited to detecting ligand interactions that do not require Na~v~ channel regions outside of the paddle region.

![CssIV interacts with the rNa~v~1.2a VSD II paddle motif. Shown is the effect of 1 µM CssIV on the rNa~v~1.2a/K~v~2.1 VSD II and IV paddle chimera. Normalized tail current voltage--activation relationships in which the tail current amplitude (I/I~max~) is plotted against test voltage (V) before (black) and in the presence of toxin (red/green) are displayed. A Boltzmann fit of the obtained data (*n* = 3; error bars represent mean ± SEM) reveals a depolarizing shift in V~1/2~ of ∼14 mV (from 33 ± 2 mV to 47 ± 1 mV) for the VSD II chimera, whereas 1 µM CssIV does not influence the VSD IV chimera. Holding voltage was −90 mV, and the tail voltage was −60 mV.](JGP_201411268_Fig4){#fig4}

DISCUSSION
==========

Collectively, our results suggest that the VSD IV paddle motif as described in this work is a self-contained unit that retains its pharmacological sensitivities toward α-scorpion toxins when isolated from the rest of the Na~v~ channel ([Fig. 3](#fig3){ref-type="fig"}). As such, we propose that a label-free SPR method may be used to detect interactions between ligands and Na~v~ channel paddle motifs without the need to express the full-length channel in a heterologous expression system. Because a full measurement cycle---including chip-regeneration steps---takes \<10 min, this biosensor approach may constitute a first step toward designing a screening method to uncover interactions between pharmacological ligands and paddle-containing ion channels. One limitation that emerged from our experiments is the inability of this method to detect ligand interactions that require regions outside of the paddle region (e.g., CssIV; [Fig. 3](#fig3){ref-type="fig"}). However, in conjunction with a report showing that paddle motif--targeting antibodies may be therapeutically beneficial ([@bib17]) or could serve as diagnostic markers ([@bib11]), the results reported here may open up a valuable pathway for discovering novel molecules that influence Na~v~ channel function by interacting with the VSDs. Moreover, our methodology can be modified to conduct competition experiments in which the displacement of toxin bound to the VSD IV paddle motif by paddle-targeting drugs can be monitored. The identification of such compounds may be useful in reshaping Na~v~ channel activity in disease conditions associated with an abnormal fast inactivation process ([@bib3]; [@bib36]; [@bib33]). In a broader context, this SPR approach could help identify ligands for VSDs not associated with a pore region ([@bib23]; [@bib26]; [@bib28]).
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